Quanterix Corporation (QTRX)
USD 5.84
(-6.04%)
USD 5.84
(-6.04%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 425.01 Million USD | -2.12% |
| 2022 | 434.19 Million USD | -13.42% |
| 2021 | 501.52 Million USD | 85.03% |
| 2020 | 271.04 Million USD | 59.48% |
| 2019 | 169.95 Million USD | 151.3% |
| 2018 | 67.62 Million USD | -26.31% |
| 2017 | 91.77 Million USD | 147.27% |
| 2016 | 37.11 Million USD | 404.92% |
| 2015 | 7.35 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 411.28 Million USD | -0.11% |
| 2024 Q1 | 411.74 Million USD | -3.12% |
| 2023 Q1 | 427.31 Million USD | -1.59% |
| 2023 FY | 425.01 Million USD | -2.12% |
| 2023 Q4 | 425.01 Million USD | -0.94% |
| 2023 Q3 | 429.04 Million USD | -0.04% |
| 2023 Q2 | 429.21 Million USD | 0.44% |
| 2022 Q1 | 504.65 Million USD | 0.62% |
| 2022 Q3 | 446.69 Million USD | -8.58% |
| 2022 FY | 434.19 Million USD | -13.42% |
| 2022 Q2 | 488.6 Million USD | -3.18% |
| 2022 Q4 | 434.19 Million USD | -2.8% |
| 2021 Q2 | 528.04 Million USD | -0.87% |
| 2021 Q4 | 501.52 Million USD | -1.82% |
| 2021 Q3 | 510.84 Million USD | -3.26% |
| 2021 FY | 501.52 Million USD | 85.03% |
| 2021 Q1 | 532.66 Million USD | 96.52% |
| 2020 Q2 | 162.94 Million USD | -4.32% |
| 2020 Q3 | 264.1 Million USD | 62.09% |
| 2020 Q4 | 271.04 Million USD | 2.63% |
| 2020 Q1 | 170.3 Million USD | 0.21% |
| 2020 FY | 271.04 Million USD | 59.48% |
| 2019 Q3 | 175.54 Million USD | 60.45% |
| 2019 Q4 | 169.95 Million USD | -3.19% |
| 2019 Q2 | 109.4 Million USD | 67.87% |
| 2019 Q1 | 65.17 Million USD | -3.63% |
| 2019 FY | 169.95 Million USD | 151.3% |
| 2018 Q3 | 71.19 Million USD | -8.46% |
| 2018 FY | 67.62 Million USD | -26.31% |
| 2018 Q2 | 77.77 Million USD | -7.06% |
| 2018 Q1 | 83.68 Million USD | -8.82% |
| 2018 Q4 | 67.62 Million USD | -5.01% |
| 2017 FY | 91.77 Million USD | 147.27% |
| 2017 Q2 | 35.17 Million USD | 9.12% |
| 2017 Q3 | 30.51 Million USD | -13.24% |
| 2017 Q4 | 91.77 Million USD | 200.77% |
| 2017 Q1 | 32.23 Million USD | -13.16% |
| 2016 Q4 | 37.11 Million USD | 0.0% |
| 2016 FY | 37.11 Million USD | 404.92% |
| 2015 FY | 7.35 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -1255.005% |
| BrainsWay Ltd. | 62.97 Million USD | -574.921% |
| Cerus Corporation | 197.74 Million USD | -114.926% |
| Envoy Medical, Inc. | 7.64 Million USD | -5462.971% |
| electroCore, Inc. | 16.38 Million USD | -2493.586% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -5425.364% |
| IceCure Medical Ltd | 16.41 Million USD | -2489.951% |
| Inogen, Inc. | 326.19 Million USD | -30.294% |
| OrthoPediatrics Corp. | 449.58 Million USD | 5.466% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -1458.53% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -2463.549% |
| MaxCyte, Inc. | 268.27 Million USD | -58.424% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -5148.79% |
| Nexalin Technology, Inc. | 3.63 Million USD | -11602.115% |
| Orthofix Medical Inc. | 925.31 Million USD | 54.069% |
| PAVmed Inc | 33.11 Million USD | -1183.285% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -196.274% |
| RxSight, Inc. | 182.55 Million USD | -132.819% |
| Sight Sciences, Inc. | 166.65 Million USD | -155.031% |
| SI-BONE, Inc. | 230.42 Million USD | -84.447% |
| TELA Bio, Inc. | 78.04 Million USD | -444.551% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -68.717% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -3860.96% |
| Acutus Medical, Inc. | 53.96 Million USD | -687.641% |
| Talis Biomedical Corporation | 98.34 Million USD | -332.185% |
| Spectral AI, Inc. | 10.69 Million USD | -3875.037% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -94.381% |
| CVRx, Inc. | 115.22 Million USD | -268.84% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -624.521% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -13542.905% |
| Bioventus Inc. | 810.91 Million USD | 47.588% |
| Venus Concept Inc. | 93.65 Million USD | -353.81% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -1552.132% |
| LivaNova PLC | 2.42 Billion USD | 82.507% |
| 908 Devices Inc. | 202.98 Million USD | -109.385% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 47.217% |
| Nemaura Medical Inc. | 14.56 Million USD | -2818.384% |
| NeuroPace, Inc. | 107.65 Million USD | -294.805% |
| LENSAR, Inc. | 69.58 Million USD | -510.78% |
| Apyx Medical Corporation | 79.24 Million USD | -436.359% |
| Cutera, Inc. | 346.29 Million USD | -22.732% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -911.546% |
| BioSig Technologies, Inc. | 1.79 Million USD | -23537.987% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -57.044% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -896.252% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 88.762% |
| Axonics, Inc. | 719.92 Million USD | 40.964% |
| Outset Medical, Inc. | 313.8 Million USD | -35.44% |
| IRIDEX Corporation | 34.43 Million USD | -1134.205% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | -5.014% |
| IRadimed Corporation | 92.15 Million USD | -361.186% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -7989.284% |
| INVO Bioscience, Inc. | 20.88 Million USD | -1934.734% |
| Telesis Bio, Inc. | 70.41 Million USD | -503.614% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -175.798% |
| Varex Imaging Corporation | 1.24 Billion USD | 65.988% |
| Quipt Home Medical Corp. | 247.4 Million USD | -71.785% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -4465.102% |
| Pulmonx Corporation | 178.95 Million USD | -137.501% |
| Dynatronics Corporation | 25.94 Million USD | -1538.403% |
| Modular Medical, Inc. | 13.8 Million USD | -2978.228% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -3862.068% |
| Semler Scientific, Inc. | 78.06 Million USD | -444.432% |
| InMode Ltd. | 863.28 Million USD | 50.768% |
| Bruker Corporation | 4.24 Billion USD | 90.0% |
| Cytosorbents Corporation | 53.26 Million USD | -697.983% |
| DexCom, Inc. | 6.26 Billion USD | 93.216% |
| Align Technology, Inc. | 6.08 Billion USD | 93.014% |
| Viveve Medical, Inc. | 25.91 Million USD | -1540.146% |
| ZimVie Inc. | 1.2 Billion USD | 64.739% |
| Movano Inc. | 9.42 Million USD | -4411.315% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 14.6% |
| Nexalin Technology, Inc. | 3.63 Million USD | -11602.115% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -624.521% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 55.387% |
| Profound Medical Corp. | 43.68 Million USD | -872.869% |
| Insulet Corporation | 2.58 Billion USD | 83.579% |
| enVVeno Medical Corporation | 48.63 Million USD | -773.879% |
| Surmodics, Inc. | 185.73 Million USD | -128.829% |
| iCAD, Inc. | 41.41 Million USD | -926.15% |
| Nuwellis, Inc. | 9.77 Million USD | -4250.164% |
| Biotricity, Inc. | 5.94 Million USD | -7051.907% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 1.878% |
| Aethlon Medical, Inc. | 8.24 Million USD | -5054.159% |
| InspireMD, Inc. | 47.64 Million USD | -792.074% |
| PAVmed Inc. | 33.11 Million USD | -1183.285% |
| BIOLASE, Inc. | 35.1 Million USD | -1110.823% |
| Beyond Air, Inc. | 56.96 Million USD | -646.144% |
| FONAR Corporation | 214.24 Million USD | -98.375% |
| AxoGen, Inc. | 196.82 Million USD | -115.931% |
| Vivani Medical, Inc. | 45.79 Million USD | -828.032% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -51.014% |
| Inari Medical, Inc. | 674.23 Million USD | 36.964% |
| UFP Technologies, Inc. | 404.13 Million USD | -5.165% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -1716.398% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -4372.334% |
| Tenon Medical, Inc. | 6.34 Million USD | -6598.361% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -4418.029% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -310.053% |
| AdaptHealth Corp. | 4.61 Billion USD | 90.8% |
| Sintx Technologies, Inc. | 15.36 Million USD | -2666.098% |
| NanoVibronix, Inc. | 6.67 Million USD | -6268.16% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -4465.102% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -691.057% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 75.658% |
| TransMedics Group, Inc. | 706.04 Million USD | 39.804% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -572.571% |
| NeuroMetrix, Inc. | 21.42 Million USD | -1883.767% |
| Hyperfine, Inc. | 94.19 Million USD | -351.184% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -58.208% |
| Biomerica, Inc. | 9.25 Million USD | -4492.727% |
| Bone Biologics Corporation | 3.73 Million USD | -11270.732% |
| AVITA Medical, Inc. | 144.33 Million USD | -194.451% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -8629.759% |
| Silk Road Medical, Inc | 265.3 Million USD | -60.195% |